Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-03-17 @ 4:34 AM
Study NCT ID:
NCT00543894
Status:
COMPLETED
Last Update Posted:
2008-08-12
First Post:
2007-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D003428', 'term': 'Cross Infection'}], 'ancestors': [{'id': 'D007239', 'term': 'Infections'}, {'id': 'D007049', 'term': 'Iatrogenic Disease'}, {'id': 'D020969', 'term': 'Disease Attributes'}, {'id': 'D010335', 'term': 'Pathologic Processes'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 500}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2006-02'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2007-06', 'lastUpdateSubmitDate': '2008-08-11', 'studyFirstSubmitDate': '2007-10-11', 'studyFirstSubmitQcDate': '2007-10-12', 'lastUpdatePostDateStruct': {'date': '2008-08-12', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2007-10-15', 'type': 'ESTIMATED'}}, 'outcomesModule': {'secondaryOutcomes': [{'measure': 'the frequency of appropriate antibiotic therapy (defined as the use of antibiotic(s) with "in vitro" efficacy against the identified pathogens responsible for the infection)'}, {'measure': 'the frequency of "the strategy of de-escalation" according to the culture results'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Antibiotic, ICU, hospital acquired infection.'], 'conditions': ['Infection in ICU']}, 'descriptionModule': {'briefSummary': 'Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A prospective, observational, multicenter study (ANTHICUS).'}, 'eligibilityModule': {'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients with hospital-acquired infections and hospitalised in the ICU at one moment of their hospital stay\n* Hospital-acquired infections accounting for eligibility are:\n\n * nosocomial pneumonia (including ventilator-associated pneumonia)\n * bacteremia\n * intra-abdominal infections\n * urosepsis'}, 'identificationModule': {'nctId': 'NCT00543894', 'acronym': 'ANTHICUS', 'briefTitle': 'Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients', 'organization': {'class': 'INDUSTRY', 'fullName': 'AstraZeneca'}, 'officialTitle': 'Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A Prospective, Observational, Multicenter Study (ANTHICUS)', 'orgStudyIdInfo': {'id': 'SRP-HB-MER-2005/1'}}, 'contactsLocationsModule': {'overallOfficials': [{'name': 'Pr Vogelaers', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'UZ Gents'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'AstraZeneca', 'class': 'INDUSTRY'}}}}